CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
IPRO›
News
IPRO

IPRO

Nonprofit healthcare quality improvement organization partnering with government agencies, providers, and consumers to measure and improve care quality.

Operating headquarters
Jericho, NY, US🇺🇸
Founded
1984
Loading
Overview
Compare
Employees
News
Library

Latest News About IPRO

The Healthcare Emergency Hub Mobile App: Emergency Planning Made Easier

IPRO - Better healthcare, realized.

The Healthcare Emergency Hub Mobile App: Emergency Planning Made Easier

For chronically ill individuals and those relying on specialized medical care, emergencies like severe weather events, natural or manmade...

Jul 28, 2026

Mary Dramitinos Named to Technical Expert Panel

IPRO - Better healthcare, realized.

Mary Dramitinos Named to Technical Expert Panel

Jericho, New York - Mary Dramitinos, MBA, Sr. Director, Managed Care Department, has been selected to participate on the Technical Expert...

Apr 27, 2026

IPRO Receives Contract to Lead CMS QIN-QIO Northeast (Region 1) Program

IPRO - Better healthcare, realized.

IPRO Receives Contract to Lead CMS QIN-QIO Northeast (Region 1) Program

Jericho, N.Y. - IPRO was recently awarded a contract from the Centers for Medicare & Medicaid Services (CMS) to serve as the Quality...

Mar 26, 2026

IPRO Implements CDC Infection Control Training in NYS Dialysis Centers

IPRO - Better healthcare, realized.

IPRO Implements CDC Infection Control Training in NYS Dialysis Centers

Project Firstline provides front-line personnel with infection prevention skills and knowledge Jericho, N.Y. –IPRO has been selected by New...

Mar 6, 2026

End-Stage Renal Disease (ESRD) Network Receives American Association of Kidney Patients Award

IPRO - Better healthcare, realized.

End-Stage Renal Disease (ESRD) Network Receives American Association of Kidney Patients Award

October 15, 2024 - IPRO End-Stage Renal Disease (ESRD) of the Ohio River Valley (Network 9) received the American Association of Kidney...

Oct 15, 2024

IPRO Achieves SOC 2 Type 2 Approval for Data Security

IPRO - Better healthcare, realized.

IPRO Achieves SOC 2 Type 2 Approval for Data Security

LAKE SUCCESS, N.Y. – IPRO, one of the nation’s leading healthcare quality improvement organizations, has completed a SOC 2 Type 2 audit and...

Sep 1, 2024